Avraham Karasik

Medicine & Life Sciences

1. Type 2 Diabetes Mellitus 100%
2. Insulin 67%
3. Insulin-Like Growth Factor I 51%
4. Phosphorylation 44%
5. Glucose 44%
6. Dipeptidyl-Peptidase IV Inhibitors 43%
7. Israel 42%
8. Glucose Intolerance 42%
9. Insulin Receptor 35%
10. Somatomedins 34%
11. Aurintricarboxylic Acid 33%
12. Cardiovascular Diseases 29%
13. Tyrosine 29%
14. Sodium-Glucose Transport Proteins 26%
15. Epidermal Growth Factor 26%
16. Insulin-Like Growth Factor Binding Protein 3 25%
17. Insulin Receptor Substrate Proteins 25%
18. Insulin-Like Growth Factor Binding Protein 2 25%
19. Acarbose 24%
20. Heart Failure 24%
21. Liraglutide 24%
22. Kidney 21%
23. empagliflozin 21%
24. Serine 20%
25. Sodium-Glucose Transporter 2 Inhibitors 18%
26. Sitagliptin Phosphate 18%
27. Proteins 18%
28. Chronic Renal Insufficiency 17%
29. Insulin Resistance 17%
30. MCF-7 Cells 17%
31. Hypertension 17%
32. Serum 16%
33. Laron Syndrome 16%
34. Hepatocytes 15%
35. Hyperinsulinism 15%
36. Metformin 15%
37. Fasting 15%
38. Annexin A1 14%
39. Liver 14%
40. ErbB Receptors 14%
41. Population 14%
42. Insulin-Like Growth Factor Binding Proteins 14%
43. Cohort Studies 14%
44. Tumor Necrosis Factor-alpha 14%
45. insulin degludec 14%
46. Follicle Stimulating Hormone 14%
47. Cell Death 14%
48. Diabetes Mellitus 14%
49. Granulosa Cells 13%
50. Therapeutics 13%